These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2762885)

  • 1. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR; Patel AR
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S; Glasser CL
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP; Ataga KI
    Am J Med Sci; 2010 Mar; 339(3):266-9. PubMed ID: 20051821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N; Mialou V; Kebaïli K; Galambrun C; Bertrand Y; Pondarre C
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.
    Diamond WJ; Brown FL; Bitterman P; Klein HG; Davey RJ; Winslow RM
    Ann Intern Med; 1980 Aug; 93(2):231-4. PubMed ID: 7406372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion.
    Milner PF; Squires JE; Larison PJ; Charles WT; Krauss JS
    South Med J; 1985 Dec; 78(12):1462-9. PubMed ID: 4071176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A delayed hemolytic transfusion reaction due to anti-Cob.
    Squires JE; Larison PJ; Charles WT; Milner PF
    Transfusion; 1985; 25(2):137-9. PubMed ID: 3984006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S; Westhoff CM; Friedman DF; Chou ST
    Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic transfusion reaction in the French hemovigilance system.
    Rieux C; Brittenham G; Bachir D; De Meyer E; Boudjedir K;
    Transfus Clin Biol; 2019 May; 26(2):109-111. PubMed ID: 30910456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A; Moreira G; Bordin JO
    Sao Paulo Med J; 1999 Jan; 117(1):38-9. PubMed ID: 10413970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Dean CL; Maier CL; Roback JD; Stowell SR
    Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of delayed hemolytic transfusion reaction.
    Pirenne F
    Transfus Clin Biol; 2019 May; 26(2):99-101. PubMed ID: 30926306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
    Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.